Ming‐Chih Lai

560 total citations
17 papers, 405 citations indexed

About

Ming‐Chih Lai is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Ming‐Chih Lai has authored 17 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Epidemiology. Recurrent topics in Ming‐Chih Lai's work include interferon and immune responses (3 papers), Hepatitis B Virus Studies (3 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Ming‐Chih Lai is often cited by papers focused on interferon and immune responses (3 papers), Hepatitis B Virus Studies (3 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Ming‐Chih Lai collaborates with scholars based in Taiwan, United States and France. Ming‐Chih Lai's co-authors include I J Su, Wenya Huang, Lily Wang, Chien‐Chung Cheng, Jee‐Fu Huang, Woan‐Yuh Tarn, Tony Realini, Laurie Barber, Kenneth L. Beattie and Cheng Su and has published in prestigious journals such as Molecular and Cellular Biology, Biochemistry and Biochemical and Biophysical Research Communications.

In The Last Decade

Ming‐Chih Lai

17 papers receiving 397 citations

Peers

Ming‐Chih Lai
Yu Dai China
Ming‐Chih Lai
Citations per year, relative to Ming‐Chih Lai Ming‐Chih Lai (= 1×) peers Yu Dai

Countries citing papers authored by Ming‐Chih Lai

Since Specialization
Citations

This map shows the geographic impact of Ming‐Chih Lai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming‐Chih Lai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming‐Chih Lai more than expected).

Fields of papers citing papers by Ming‐Chih Lai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming‐Chih Lai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming‐Chih Lai. The network helps show where Ming‐Chih Lai may publish in the future.

Co-authorship network of co-authors of Ming‐Chih Lai

This figure shows the co-authorship network connecting the top 25 collaborators of Ming‐Chih Lai. A scholar is included among the top collaborators of Ming‐Chih Lai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming‐Chih Lai. Ming‐Chih Lai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Lai, Ming‐Chih, et al.. (2024). DDX 3 participates in mi RNA biogenesis and RNA interference through translational control of PACT and interaction with AGO 2. FEBS Open Bio. 15(1). 180–195. 1 indexed citations
2.
Tsai, Shih‐Chang, Chih‐Hung Lin, Yuting Jiang, et al.. (2024). DDX3 is critical for female fertility via translational control in oogenesis. Cell Death Discovery. 10(1). 472–472. 2 indexed citations
4.
Lai, Ming‐Chih, et al.. (2021). DDX3 interacts with USP9X and participates in deubiquitination of the anti‐apoptotic protein MCL1. FEBS Journal. 289(4). 1043–1061. 9 indexed citations
5.
Cheng, Yi‐Chuan, et al.. (2018). DDX3 Participates in Translational Control of Inflammation Induced by Infections and Injuries. Molecular and Cellular Biology. 39(1). 34 indexed citations
6.
Lai, Ming‐Chih, et al.. (2015). DDX3 functions in antiviral innate immunity through translational control of PACT. FEBS Journal. 283(1). 88–101. 28 indexed citations
7.
Wang, Lily, Wenya Huang, Ming‐Chih Lai, & I J Su. (2011). Aberrant cyclin A expression and centrosome overduplication induced by hepatitis B virus Pre-S2 mutants and its implication in hepatocarcinogenesis. Carcinogenesis. 33(2). 466–472. 61 indexed citations
8.
Chang, Wen‐Wei, Ih Jen Su, Ming‐Chih Lai, et al.. (2008). Suppression of p38 mitogen-activated protein kinase inhibits hepatitis B virus replication in human hepatoma cell: the antiviral role of nitric oxide. Journal of Viral Hepatitis. no–no. 14 indexed citations
9.
Chang, Wen‐Wei, et al.. (2008). Suppression of p38 mitogen-activated protein kinase inhibits hepatitis B virus replication in human hepatoma cell: the antiviral role of nitric oxide. Journal of Viral Hepatitis. 15(7). 490–497. 24 indexed citations
11.
Realini, Tony, Ming‐Chih Lai, & Laurie Barber. (2004). Impact of diabetes on glaucoma screening using frequency-doubling perimetry. Ophthalmology. 111(11). 2133–2136. 39 indexed citations
12.
Lei, Huan‐Yao, et al.. (2000). Induction of antitumor immunity with combination of HER2/neu DNA vaccine and interleukin 2 gene-modified tumor vaccine.. PubMed. 6(11). 4381–8. 26 indexed citations
13.
Huang, Jee‐Fu, et al.. (1999). Pharmacokinetics of metoprolol enantiomers in Chinese subjects of major genotypes. Clinical Pharmacology & Therapeutics. 65(4). 402–407. 56 indexed citations
14.
Lü, Tian‐Feng, et al.. (1997). Tyrosine kinase expression profile in bladder cancer.. PubMed. 17(4A). 2635–7. 8 indexed citations
15.
Jc, Lee, et al.. (1995). Analysis of K-ras gene mutations in periampullary cancers, gallbladder cancers and cholangiocarcinomas from paraffin-embedded tissue sections.. PubMed. 94(12). 719–23. 10 indexed citations
16.
Liu, Bernard Haochih, et al.. (1993). Release of the p53-Induced Repression on Thymidine Kinase Promoter by Single p53-Binding Sequence. Biochemical and Biophysical Research Communications. 191(2). 662–668. 9 indexed citations
17.
Lai, Ming‐Chih & Kenneth L. Beattie. (1988). Influence of DNA sequence on the nature of mispairing during DNA synthesis. Biochemistry. 27(5). 1722–1728. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026